Shuttle Pharmaceuticals Holdings (SHPH) said in a filing with the US Securities and Exchange Commission that it is offering common shares, pre-funded warrants to buy shares, and warrants to purchase shares.
The company did not disclose the terms of the offering including pricing and number of shares, pre-funded warrants and warrants.
Shuttle plans to use the net proceeds from the offering to fund trials of product candidates, and pay $2.3 million owed to clinical research organization Theradex Systems.
Shares of Shuttle Pharmaceuticals were down nearly 6% in recent trading.
Price: 1.53, Change: -0.09, Percent Change: -5.68
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments